81
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Proteoglycan induced coagulopathy in myeloma – a rare phenomenon

, ORCID Icon, , , , & show all
Pages 492-494 | Received 24 Jul 2020, Accepted 28 Sep 2020, Published online: 19 Oct 2020

References

  • Saif MW, Allegra CJ, Greenberg B. Bleeding diathesis in multiple myeloma. J Hematother Stem Cell Res. 2001;10(5):657–660.
  • Botín T, Oriol A, Orna E, et al. Paraprotein-related bleeding as a first symptom of multiple myeloma. J Leuk. 2015;3:183.
  • Kawashima I, Takano K, Kumagai T, et al. Combined coagulopathy can induce both hemorrhagic and thrombotic complications in multiple myeloma. Intern Med. 2018;57(22):3303–3306.
  • Robert F, Mignucci M, McCurdy SA, et al. Hemostatic abnormalities associated with monoclonal gammopathies. Am J Med Sci. 1993;306(6):359–366.
  • Chapman GS, George CB, Danley DL. Heparin-like anticoagulant associated with plasma cell myeloma. Am J Clin Pathol. 1985;83(6):764–766.
  • Willner CA, Chisti MM. Treatment of bleeding diathesis associated with a heparin-like anticoagulant in plasma cell neoplasia using protamine. Hindawi Case Rep Hematol. 2018;2018:1–3.
  • Teng HW, Chen PM, Yang YH, et al. The prolonged activated partial thromboplastin time at diagnosis indicates less favorable prognosis in IgA myeloma. Jpn J Clin Oncol. 2007;37(8):609–614.
  • Perkins HA, MacKenzie MR, Fudenberg HH. Hemostatic defects in dysproteinemias. Blood. 1970;35(5):695–707.
  • Khoory MS, Nesheim ME, Bowie EJW, et al. Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. J Clin Invest. 1980;65(3):666–674.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.